Hixita-M 50 Tablet
Hixita-M 50 Tablet
Sitagliptin (50mg) + Metformin (500mg)
Janular 50/500 Tablet
Vallalar Medical
Sitagliptin 50mg
Pack Size
strip of 15 tablets
Price
Save ₹8
that's 10% off!
About This Medicine
Product description & overview
Hixita-M 50 Tablet: A Combination Therapy for Diabetes Management
Hixita-M 50 Tablet is a convenient combined medication specifically designed to manage type 2 diabetes. This tablet contains a precise blend of Sitagliptin (50mg) and Metformin (500mg).
Sitagliptin works by inhibiting the enzyme DPP-4, which slows down the breakdown of incretin hormones in the body. These hormones enhance glucose uptake and decrease blood sugar levels.
Metformin, a biguanide drug, improves insulin sensitivity, reducing insulin resistance and lowering blood glucose production by the liver.
Hixita-M 50 Tablet offers a simplified approach to managing diabetes by combining these two powerful components for effective glycemic control. It is crucial to consult your doctor before starting any new medication regimen.
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Sitagliptin
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Hixita-M 50 Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Hixita-M 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Hixita-M 50 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Hixita-M 50 Tablet may be needed. Please consult your doctor. Use of Hixita-M 50 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Hixita-M 50 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Hixita-M 50 Tablet
Products matching your search
Olmezest H 40 Tablet
Olmezest H 40 Tablet
Enzorab 20 Tablet
Enzorab 20 Tablet
G-Triglim 2 Tablet SR
G-Triglim 2 Tablet SR
Olkem 20H Tablet
Olkem 20H Tablet
Enzoxy Max Capsule
Enzoxy Max Capsule
Fepanil-Mef DS Oral Suspension Delicious Orange
Fepanil-Mef DS Oral Suspension Delicious Orange
Foxin Eye Drop
Foxin Eye Drop
Losartas 25 Tablet